High blood pressure can lead to liver fibrosis – the gradual stiffening of your liver as thin bands of scar tissue gradually ...
Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...
PFIC is a group of rare genetic diseases that cause progressive liver failure. The exact prevalence of PFIC is unknown, but ...
Health experts highlight the importance of maintaining liver health due to the rising concern over fatty liver conditions.
The global liver fibrosis treatment market is poised for substantial growth, with revenue projections increasing from USD 17.51 billion in 2024 to USD 51.16 billion by 2033. This expansion represents ...
The global rise in obesity and type 2 diabetes is fueling an epidemic of MASLD and MASH, now recognized as the leading cause ...
A study published in Nature Aging has revealed a promising new drug candidate that may help combat metabolic dysfunction-associated steatotic liver disease (MASLD), a chronic liver condition that ...
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD) ...
March 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology process, today announced new 'in ...
Solute carrier (SLC) family transporters are crucial transmembrane proteins responsible for transporting various molecules, ...